Chronic heart failure and the substrate for atrial fibrillation

Cardiovasc Res. 2009 Nov 1;84(2):227-36. doi: 10.1093/cvr/cvp216. Epub 2009 Jun 30.

Abstract

Aims: We sought to define the underlying mechanisms for atrial fibrillation (AF) during chronic heart failure (HF).

Methods and results: Preliminary studies showed that 4 months of HF resulted in irreversible systolic dysfunction (n = 9) and a substrate for sustained inducible AF (>3 months, n = 3). We used a chronic (4-month) canine model of tachypacing-induced HF (n = 10) to assess atrial electrophysiological remodelling, relative to controls (n = 5). Left ventricular fractional shortening was reduced from 37.2 +/- 0.83 to 13.44 +/- 2.63% (P < 0.05). Left atrial (LA) contractility (fractional area change) was reduced from 34.9 +/- 7.9 to 27.9 +/- 4.23% (P < 0.05). Action potential durations (APDs) at 50 and 90% repolarization were shortened by approximately 60 and 40%, respectively, during HF (P < 0.05). HF-induced atrial remodelling included increased fibrosis, increased I(to), and decreased I(K1), I(Kur), and I(Ks) (P < 0.05). HF induced increases in LA Kv channel interacting protein 2 (P < 0.05), no change in Kv4.3, Kv1.5, or Kir2.3, and reduced Kir2.1 (P < 0.05). When I(Ca-L) was elicited by action potential (AP) clamp, HF APs reduced the integral of I(Ca) in control myocytes, with a larger reduction in HF myocytes (P < 0.05). I(CaL) measured with standard voltage clamp was unchanged by HF. Incubation of myocytes with N-acetylcysteine (a glutathione precursor) attenuated HF-induced electrophysiological alterations. LA angiotensin-1 receptor expression was increased in HF.

Conclusion: Chronic HF causes alterations in ion channel expression and ion currents, resulting in attenuation of the APD and atrial contractility and a substrate for persistent AF.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Action Potentials
  • Animals
  • Atrial Fibrillation / etiology*
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology
  • Atrial Function, Left
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling
  • Cardiac Pacing, Artificial
  • Chronic Disease
  • Disease Models, Animal
  • Dogs
  • Female
  • Fibrosis
  • Heart Conduction System / drug effects
  • Heart Conduction System / metabolism
  • Heart Conduction System / physiopathology*
  • Heart Failure / complications*
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Male
  • Myocardial Contraction
  • Myocardium / metabolism
  • Myocardium / pathology
  • Oxidation-Reduction
  • Oxidative Stress
  • Pilot Projects
  • Potassium Channels / metabolism
  • Receptor, Angiotensin, Type 1 / metabolism
  • Refractory Period, Electrophysiological
  • Time Factors
  • Ventricular Function, Left

Substances

  • Calcium Channels, L-Type
  • Potassium Channels
  • Receptor, Angiotensin, Type 1
  • Acetylcysteine